Angeles Clinic and Research Institute

Los Angeles, California 90025

0 studies enrolling now · 5 studies all time

What they study most

Advanced Cancer, Advanced Solid Tumor, Melanoma, Metastatic Cancer, Pathologically Confirmed Cancer Refractory to Conventional Therapy, Recurrent Cancer, Refractory Cancer, Select Advanced Solid Tumors, Skin Cancer, Solid Tumor, Solid Tumor, Adult, Solid Tumors

Studies at this site

• Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors — Running, not enrolling
• Safety, Tolerability, and Immunogenicity of mRNA-4157 Alone and in Combination in Participants With Solid Tumors — Running, not enrolling
• Study of Allogeneic Blood-derived Natural Killer Cells to Evaluate Safety and Tolerability in Cancer Refractory to Conventional Therapy — Completed
• An Investigational Immuno-therapy Study to Evaluate Safety and Effectiveness in Patients With Melanoma That Has Spread to the Brain, Treated With Nivolumab in Combination With Ipilimumab, Followed by Nivolumab by Itself — Completed
• An Investigational Immuno-therapy Study of BMS-986205 Combined With Nivolumab, Compared to Nivolumab by Itself, in Patients With Advanced Melanoma — Completed